Internal Medicine · Clarkston, MI
NPI
1598733693
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5905 S Main St, Suite 2
Clarkston, MI, 48346
Phone (248) 620-3700
Groups this clinician bills Medicare through
Medicare paid, 2024
$94K
1,681 services
Medicare patients, 2024
211
Average age 72
Drug cost, 2024
$1.4M
13,029 prescriptions
Company payments, 2025
$1,419
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Narin Tanir-Avci was code 99213 (office e&m - established), 284 times for 138 patients. In total Narin Tanir-Avci billed 1,681 services in 43 codes, and Medicare paid $94K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 284 | 138 | $63.14 | $18K |
| 99232 Hospital E&M - Subsequent | Facility | 188 | 34 | $62.94 | $12K |
| G0136 Administration of a standardized, evidence-based social determinants of health risk assessment tool, 5-15 minutes | Office | 143 | 142 | $12.78 | $1,827 |
| 99497 Care Management/Coordination | Office | 127 | 125 | $73.01 | $9,272 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 126 | 126 | $128.54 | $16K |
| 81002 Clinical Chemistry | Office | 125 | 80 | $3.36 | $420 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 118 | 118 | $18.61 | $2,196 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 108 | 108 | $18.60 | $2,009 |
| 99214 Office E&M - Established | Office | 101 | 69 | $96.45 | $9,741 |
| 99233 Hospital E&M - Subsequent | Facility | 50 | 41 | $94.68 | $4,734 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 37 | 33 | $162.60 | $6,016 |
| 99222 Hospital E&M - Initial | Facility | 37 | 31 | $104.88 | $3,880 |
| 96372 Injection Administration | Office | 31 | 26 | $10.19 | $316 |
| 96160 E&M - Miscellaneous | Office | 29 | 27 | $2.14 | $62.07 |
| 93000 Electrocardiogram | Office | 22 | 18 | $9.90 | $218 |
By year: 2022 $95K for 1,666 services; 2023 $100K for 1,696 services; 2024 $94K for 1,681 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 125 | 80 | $3.36 | $420 |
Medicare prescription drug claims, 2024
In 2024, the drug Narin Tanir-Avci prescribed most often to Medicare patients was Levothyroxine Sodium, with 486 prescriptions and refills. In total Narin Tanir-Avci wrote 13,029 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 486 | 1,243 | 119 | $6,472 |
| Rosuvastatin Calcium Generic | 482 | 1,299 | 145 | $7,591 |
| Losartan Potassium Generic | 446 | 1,219 | 132 | $5,814 |
| Atorvastatin Calcium Generic | 423 | 1,033 | 106 | $5,108 |
| Lisinopril Generic | 396 | 954 | 97 | $3,356 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 366 | 366 | 69 | $5,715 |
| Metoprolol Succinate Generic | 341 | 900 | 103 | $5,511 |
| Omeprazole Generic | 314 | 672 | 78 | $4,560 |
| Prednisone Generic | 292 | 307 | 171 | $487 |
| Amlodipine Besylate Generic | 268 | 720 | 77 | $1,837 |
| Pantoprazole Sodium Generic | 245 | 581 | 74 | $4,478 |
| Gabapentin Generic | 223 | 295 | 47 | $2,636 |
| Metformin Hcl Generic | 196 | 485 | 48 | $2,218 |
| Pravastatin Sodium Generic | 191 | 477 | 46 | $3,275 |
| Glimepiride Generic | 182 | 438 | 50 | $2,161 |
Brand drugs: 1,826 claims; generic drugs: 11,082 claims; opioid claims: 497.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Narin Tanir-Avci $1,419 ($1,419 in general payments such as food, travel and fees) from 17 companies. The largest payer was Novo Nordisk Inc with $307.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 18 | $307 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 23 | $270 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $170 |
| Lilly USA, LLC LLY | 6 | $107 |
| Astellas Pharma US Inc 4503.T | 5 | $90.43 |
| Lundbeck LLC | 4 | $89.46 |
| Abbvie Inc. ABBV | 4 | $82.3 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $72.97 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $55.96 |
| Amgen Inc. AMGN | 2 | $38.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.